Mixed Results for Oral Lupus Drug in Phase II

(MedPage Today) -- What could be the first oral medication specific for systemic lupus erythematosus (SLE) was more effective than placebo in a randomized phase II trial, though the results were something less than a home run.
With 288 patients...

Source: MedPage Today Rheumatology - March 16, 2022 Category: Rheumatology Source Type: news